Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides
Bone Marrow Transplant
.
2022 Nov;57(11):1724-1726.
doi: 10.1038/s41409-022-01787-3.
Epub 2022 Aug 26.
Authors
Jessica Elliott
1
,
Shalini Ahlawat
2
,
H Miles Prince
2
3
,
Glen Kennedy
4
,
Jillian Wells
5
,
Gillian Huang
5
,
Jenny Collins
2
,
Peter Bardy
6
,
Carrie Van Der Weyden
2
,
David Ritchie
2
,
Amit Khot
2
3
Affiliations
1
Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia. jessica.elliott@petermac.org.
2
Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
3
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
4
Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
5
Westmead Hospital, Sydney, NSW, Australia.
6
Royal Adelaide Hospital, Adelaide, SA, Australia.
PMID:
36028756
DOI:
10.1038/s41409-022-01787-3
No abstract available
Publication types
Letter
MeSH terms
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation*
Humans
Mycosis Fungoides* / therapy
Sezary Syndrome* / therapy
Skin Neoplasms* / therapy